Keisuke Tonouchi 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（15 件）

• [2025] On the carrying capacity of the bone marrow survival niche in mice
  DOI: https://doi.org/10.3389/fimmu.2025.1706810
• [2025] Antibody durability is influenced by interleukin-2 production by undifferentiated memory T helper cells and extensive B cell clonal expansion
  DOI: https://doi.org/10.1016/j.celrep.2025.115934
• [2023] Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses
  DOI: https://doi.org/10.1016/j.vaccine.2023.06.019
• [2023] CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes
  DOI: https://doi.org/10.1126/sciadv.adf0661
• [2023] Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope
  DOI: https://doi.org/10.1371/journal.ppat.1011554
• [2023] Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
  DOI: https://doi.org/10.1038/s41467-023-39890-8
• [2022] SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype
  DOI: https://doi.org/10.1016/j.isci.2022.104959
• [2022] Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine
  DOI: https://doi.org/10.1016/j.xcrm.2022.100631
• [2022] SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine
  DOI: https://doi.org/10.1126/sciimmunol.abn8590
• [2021] A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site
  DOI: https://doi.org/10.1016/j.immuni.2021.08.025

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。